13.57MMarket Cap-0.32P/E (TTM)
1.1760High1.0924Low745.57KVolume1.1100Open1.0900Pre Close854.13KTurnover7.00%Turnover RatioLossP/E (Static)11.80MShares21.600052wk High1.00P/B12.26MFloat Cap0.843552wk Low--Dividend TTM10.66MShs Float100075500.0000Historical High--Div YieldTTM7.67%Amplitude0.8430Historical Low1.1450Avg Price1Lot Size
Jaguar Health Stock Forum
FDA Approves Orphan-Drug Designation for Jaguar Health's Crofelemer for Treatment of Diarrhea in Cholera
Tuesday, 17th December at 8:30 am
World Health Organization (WHO) has classified the global resurgence of cholera at the highest internal level for emergencies; 1.3 to 4 million cholera cases and 21,000 to 143,000 cholera-related deaths occur each year worldwide
Cholera is an acute diarrheal illness caused by infection of the intestine with the bacterium Vibrio ch...
Significant Positive Results with Jaguar Health's Crofelemer for Cancer Therapy-Related Diarrhea (CTD) in Breast Cancer Patients Presented at San Antonio Breast Cancer Symposium (SABCS)
Thursday, 12th December at 9:00 am
Adult patients with breast cancer are a prespecified subgroup of the recently conducted phase 3 OnTarget trial evaluating crofelemer for prophylaxis of CTD
The majority of patients in the OnTarget placebo group on abemaciclib and pertuzumab-based the...
No comment yet